$VRTX High call buying with 25% potential gain by MAY 24th
This is not a name we are overly familiar with but in the past few weeks, we have noticed numerous upgrades and some large funds increasing exposure in the name. Finally higher than normal option activity was spotted on Friday with a significant upside return on the strike price. Like all Pharma stocks good news can be very good for the stock price, so keep watch.
VERTEX PHARMACEUTICALS INC.
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis
VERTEX PHARMACEUTICALS INC.
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis